CAS: 726169-73-9 - N-(2-aminophenyl)-4-{[(4-pyridin-3-ylpyrimidin-2-yl)amino]methyl}benzamide

Formel: C₂₃H₂₀N₆O

InChl: InChI=1S/C23H20N6O/c24-19-5-1-2-6-21(19)28-22(30)17-9-7-16(8-10-17)14-27-23-26-13-11-20(29-23)18-4-3-12-25-15-18/h1-13,15H,14,24H2,(H,28,30)(H,26,27,29)

InChI Key: InChIKey=HRNLUBSXIHFDHP-UHFFFAOYSA-N

SMILES: O=C(NC=1C=CC=CC1N)C2=CC=C(C=C2)CNC=3N=CC=C(N3)C4=CN=CC=C4

Synonyme:

• Mg 0103
• Mgcd 0103
• Mocetinostat
• N-(2-Aminophenyl)-4-[[[4-(3-pyridinyl)-2-pyrimidinyl]amino]methyl]benzamide
• N-(2-aminophenyl)-4-((4-pyridin-3-ylpyrimidin-2-ylamino)methyl)benzamide
• N-(2-aminophenyl)-4-({[4-(pyridin-3-yl)pyrimidin-2-yl]amino}methyl)benzamide
• benzamide, N-(2-aminophenyl)-4-[[[4-(3-pyridinyl)-2-pyrimidinyl]amino]methyl]-

N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide

CAS: 726169-73-9

• Formel: C₂₃H₂₀N₆O
• Reinheit: 98%
• Farbe und Form: Solid
• Molekulargewicht: 396.4445

Mocetinostat

CAS: 726169-73-9

Mocetinostat (MG0103) is an orally available HDAC inhibitor with most potency for HDAC1 (IC50: 0.15 …

• Formel: C₂₃H₂₀N₆O
• Reinheit: 99% - 99.37%
• Farbe und Form: Solid
• Molekulargewicht: 396.44

Mocetinostat

CAS: 726169-73-9

Applications Mocetinostat is a multi-targeted histone deacetylase inhibitor used in cancer therapy. Mocetinostat is undergoing …

• Formel: C₂₃H₂₀N₆O
• Farbe und Form: Neat
• Molekulargewicht: 396.44

Mocetinostat

CAS: 726169-73-9

Inhibitor of class I histone deacetylases

• Formel: C₂₃H₂₀ON₆
• Reinheit: Min. 95%
• Molekulargewicht: 396.44 g/mol